Encompass Health (NYSE:EHC) Receives “Outperform” Rating from Royal Bank of Canada

Royal Bank of Canada reissued their outperform rating on shares of Encompass Health (NYSE:EHCFree Report) in a research note issued to investors on Friday morning, Benzinga reports. They currently have a $83.00 price objective on the stock.

EHC has been the topic of several other reports. Stephens restated an overweight rating and set a $85.00 target price on shares of Encompass Health in a research report on Tuesday, January 16th. William Blair reaffirmed an outperform rating on shares of Encompass Health in a research note on Wednesday, February 7th. Finally, Mizuho raised their price target on Encompass Health from $77.00 to $82.00 and gave the stock a buy rating in a research note on Friday. One investment analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of Buy and a consensus target price of $79.89.

Check Out Our Latest Report on Encompass Health

Encompass Health Trading Up 0.8 %

NYSE:EHC opened at $73.52 on Friday. The firm has a market cap of $7.37 billion, a P/E ratio of 21.19, a PEG ratio of 1.31 and a beta of 0.92. The company has a current ratio of 1.28, a quick ratio of 1.27 and a debt-to-equity ratio of 1.19. The stock’s 50 day simple moving average is $68.83 and its 200-day simple moving average is $67.57. Encompass Health has a 12-month low of $51.15 and a 12-month high of $76.84.

Institutional Investors Weigh In On Encompass Health

Large investors have recently made changes to their positions in the company. Principal Securities Inc. bought a new stake in shares of Encompass Health during the 4th quarter worth about $25,000. Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 360.2% during the fourth quarter. Benjamin F. Edwards & Company Inc. now owns 405 shares of the company’s stock worth $27,000 after buying an additional 317 shares in the last quarter. McGlone Suttner Wealth Management Inc. acquired a new stake in shares of Encompass Health during the 4th quarter valued at about $30,000. GAMMA Investing LLC acquired a new stake in shares of Encompass Health during the 4th quarter valued at about $33,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Encompass Health in the 3rd quarter valued at $35,000. Institutional investors own 92.66% of the company’s stock.

About Encompass Health

(Get Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States. It provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Featured Articles

Analyst Recommendations for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.